Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Litaier Pharmaceutical is a comprehensive pharmaceutical enterprise located in the China Medical City (CMC) of Taizhou, Jiangsu Province. The company focuses on the research, development, and large-scale production of chemical drugs, with a specialized portfolio in gastroenterology, cardiovascular health, and anti-infective therapies. Its manufacturing facilities are GMP-certified and equipped to produce various dosage forms, including small-volume injections, large-volume infusions, and oral solid preparations. Litaier is recognized for its commercialized generic products such as Esomeprazole Sodium and Amlodipine Besylate, which serve significant patient populations in the Chinese domestic market. The company continues to expand its pipeline through internal R&D and strategic positioning within one of China's premier medical high-tech zones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏利泰尔药业.